TELA BIO INC. - COMMON STOCK

TELA Bio to Participate in the 41st Annual J.P. Morgan Healthcare Conference

21 12 2022 07:00:00 提供 Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

09 12 2022 16:02:00 提供 Nasdaq GlobeNewswire

TELA Bio to Participate in Piper Sandler 34th Annual Healthcare Conference

21 11 2022 07:00:00 提供 Nasdaq GlobeNewswire

TELA Bio Reports Third Quarter 2022 Financial Results

09 11 2022 16:01:00 提供 Nasdaq GlobeNewswire

TELA Bio to Participate in Canaccord MedTech, Diagnostics and Digital Health & Services Forum

03 11 2022 07:00:02 提供 Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

28 10 2022 16:05:00 提供 Nasdaq GlobeNewswire

TELA Bio to Announce Third Quarter 2022 Financial Results

27 10 2022 07:00:01 提供 Nasdaq GlobeNewswire

TELA Bio Announces Publication of 24-Month BRAVO Study Results Demonstrating Benefits of OviTex® Reinforced Tissue Matrix in Hernia Repair

26 10 2022 07:00:00 提供 Nasdaq GlobeNewswire

TELA Bio to Participate in Upcoming Investor Conferences

01 9 2022 07:00:01 提供 Nasdaq GlobeNewswire

TELA Bio to Participate in Inaugural Gilmartin Group Emerging Growth Company Showcase

23 8 2022 16:01:00 提供 Nasdaq GlobeNewswire

TELA Bio Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter’s Option to Purchase Additional Shares

18 8 2022 16:01:00 提供 Nasdaq GlobeNewswire

TELA Bio Announces Pricing of Public Offering of Common Stock

15 8 2022 22:20:00 提供 Nasdaq GlobeNewswire

TELA Bio Announces Proposed Public Offering of Common Stock

15 8 2022 16:01:00 提供 Nasdaq GlobeNewswire

TELA Bio Reports Second Quarter 2022 Financial Results

10 8 2022 16:01:00 提供 Nasdaq GlobeNewswire

TELA Bio to Participate in Upcoming Investor Conferences

05 8 2022 07:00:00 提供 Nasdaq GlobeNewswire

TELA Bio Highlights Results from BRAVO and ReBAR Studies on the Benefits of OviTex® Reinforced Tissue Matrix in Hernia Repairs; Data to Be Presented at 2022 American Hernia Society (AHS) Meeting

04 8 2022 07:00:02 提供 Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

29 7 2022 16:01:00 提供 Nasdaq GlobeNewswire

TELA Bio to Announce Second Quarter 2022 Financial Results

27 7 2022 07:00:00 提供 Nasdaq GlobeNewswire

TELA Bio Awarded Synthetic Bioabsorbable Mesh Products Agreement with Premier, Inc.

20 7 2022 07:00:00 提供 Nasdaq GlobeNewswire

TELA Bio to Participate in Upcoming JMP Securities Life Sciences Conference

02 6 2022 07:00:00 提供 Nasdaq GlobeNewswire